Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System

NCT06990048 is registered in ClinicalTrials.gov with Endologix as lead sponsor.

NCT NCT06990048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06990048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System
Lead sponsor
Endologix
Phase
Observational
Overall status
Active, not recruiting
Start date
September 21, 2023
Completion date
May 31, 2027
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal aortic aneurysm